Phronesis Artificial Intelligence, Inc.

Phronesis AI is revolutionizing small-molecule drug discovery through fully autonomous design of novel compounds—delivered in days rather than months. Our AI-powered LIME platform transforms raw protein structures (e.g., PDB files) into tailored, drug-like molecules by letting users define desired properties such as biological activity, synthetic cost, and drug-likeness. . 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗲𝘀𝗶𝗴𝗻: Creates novel, receptor-targeted molecules from just an active-site structure . 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝗿𝗲𝘁𝗿𝗼𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀: Automatically generates detailed, cost-effective synthetic routes with confidence scores and precursor information phronesisai.com 𝗥𝗼𝗯𝗼𝘁𝗶𝗰 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻 (𝗶𝗻 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁): Supports machine-readable synthesis protocols and wet-lab testing through robotic automation—slashing development time, cost, and variability. 𝗣𝗵𝗿𝗼𝗻𝗲𝘀𝗶𝘀 𝗔𝗜’𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝘀 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗽𝗶𝗽𝗲𝗹𝗶𝗻𝗲 —from molecular design and retrosynthesis planning to seamless robotic execution—helping researchers accelerate discovery, reduce failure, and maintain full control of their data and IP.